Patent ID: 9474773
Filing Date: 2016-10-25
CPC Classification: A23C,A23G,A23L,A23V,A23Y,A61K,A61P,C12N

Claim Text:
1. A method for alleviating type 1 diabetes (T1D) in a human subject, wherein said method comprises orally administering to a human subject identified as having, or identified as being at risk for, T1D, a composition comprising an effective amount of an isolated, naturally-occurring probiotic Lactobacillus strain selected from Lactobacillus reuteri and Lactobacillus johnsonii , wherein said composition further comprises a carrier, and wherein said method comprises orally administering to the human subject Lactobacillus johnsoni N6.2 having ATCC Accession No. PTA-122064.